This data-based intelligencer will continue to be updated based on new financial documents so that readers can stay modern. Companies must submit with SEC or SEDAR and be modern to be considered for inclusion. When we started this resource in May 2019, quarterly-income companies, more than $ 2.5 million. As the industry has received a scale, since more companies have published, we later raised the minimum, including $ 12.5 million on September 2020. $ 50 million ($ 68.8 million), and the junior list now has at least $ 25 million ($ 34.4 million).
Note about regulated operating income
In May 2019 we added an additional meter, “adjusted operating income” We detailed In our news. The calculation takes the reported operating income and adjusts it for any change in the real value of biological assets required under IFRS accounting. We believe that this adjustment improves the comparison of companies in IFRS and NAS accounting. We note that frequently income can include one-time compensation, inventory writing or public listing costs, and we recommend that readers understand this unterior materials on quarterly finance. Many companies have been transferred from ITMS to NAS Account, which reduced our need to make adjustments. Please note that our ranking includes only actual reported income and not Pro Forma IncomeWe also note that companies with non-Cannabis actions should provide financial statements in the level of sector, which details not only income, but also operating profits, which must have their operating profits. Aurora Canepis is currently (TSX: ACB), Jazz Pharma (NASDAQ: JH) and TILRAY (TSX: TLRY) does not provide this information.
Tracker Inclusion Updates:
On July 27, at the time of our latest update, 16 companies are qualified for the inclusion of senior lists, including $ 13 and 3 in Canadian currency and 3 have had 13 companies. Currently, 13 companies presenting US dollars and 3 that file in Canadian dollars are the Senior lists, 16 in total. The younger list includes 11 companies that make 11 companies in Canadian dollars. The income of the public Cannabis and the income search engine now includes 29 companies. One company, farmland (NASDAQ. In Canada, both junior list names, canopy growth and organ have moved to a senior list.
Companies were reported to be reported in late July
Since our latest update, almost all Armenian companies have announced their June quarterly reports.
Senior and Junior – US Dollar Report
All recently reported all five MSOS, and the results were not particularly impressive. Curaleaf (OTC: Curlf) (TSX: Cura) has saved the income leader, which decreased by 8% a year ago. Thuelieve (OTC: TCNNF) (CSE: TRUL) saw the income unchanged a year ago. Green Thumb Industries (OTC: GTBIF) (CSE: GTII) has experienced an income that increased by 5% compared to the previous year, but operating profits were sharply dipped. Verano Holdings (OTC: VRNOF) (NEO: VRNO) MSOS was 4th place in MSOS, but its income fell a year ago. CRESCO LABS (OTC: CRLBF) (CSE: CL) had the largest biggest MSOS downfall.
Looking ago, all senior list companies reported, although there are several companies in the junior list that have not yet been submitted. Before mid-November, none of the 5 largest MSOs provided for their Q3 financial statements, but here are the current prospect by Learn:
Curaleaf (OTC: Curlf) (TSX: Cura) – Revenues will drop from 4% to 317.2 million dollars, $ 10%
Thuelieve (OTC: TCNNF) (CSE:
Green Thumb Industries (OTC: GTBII) (CSE: GTII) – Revenues are expected to increase by 1% by 291.0 million dollars, 82.3 million dollars
Verano Holdings (OTC: VRNOF) (Neo: VRNO) – Revenues will be reduced from 6% to $ 203.1 million, with an Ebitda, 6% to $ 60.6 million
Cresco Labs (OTC: CLBF) (CSE: CL) – Revenues will be reduced by 9% to $ 163.8 million adjusted eBitda, decreased by $ 36.7 million
Senior and Junior – Canadian Dollar Report
Nipple (NASDAQ: SNDL) (CSE: SNDL) is possible cannabis income and a year ago. Aurora hemp (NASDAQ. ACB) (TSX: ACB) The revenues seen again a year ago, but slipped successively. Canopy (NASDAQ. CGC) (TSX. Weed) had a great operational loss, although it was a decline a year ago. Organic global (NASDAQ. OGI) (TSX. OGI) has shown a large increase in revenue that stimulates achievements.
Currently, there are still calls for senior companies.
Cannabis Cannabis Revenue Tracker is not a proposal by New Cannabis Ventures, and you should not use it as investment advice. Tilde next to the date means an approximate date. All calculations come from sec or sedar files. For any question or licensing requests please Contact usA number
Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email
Hemp stocks, as measured by the Global Hemp Stock Index, were quite volatile in 2024 and then again in 2025 as well. The index fell 7.5% in December last year to close 15.2% lower for the year, and it was also a poor start to 2025. It hit a new all-time high of 4.97 on the last day of March, before falling back in early April. The index gained 11.5% in April, but ended the second quarter from there, closing at 5.02. Q3 was strong with increases in July and August, and September, which started with a pullback, ended with another increase before pulling back on the last day. The index ended September down just a little, before falling in October and even lower in November. It rose sharply in December, rising 8.4% to 6.59. While stocks rose, 13 of the index’s 28 names declined for the month.
After collapsing 21.8% in late 2024 to 6.88 in Q4, the index fell heavily in Q1 and then marginally in Q2. The global hemp stock index, which now has 28 members, fell 27% year-to-date in June. After a 53.0 percent rally in the third quarter, the index increased by 11.6 percent compared to last year. It fell 14.2% in the 4th quarter and was down 4.2% for the full year.
Since its peak in February 2021, the global hemp stock index is down 92.9% from a closing high of 92.48.
The 3 strongest names in December, each an MSO, are all up more than 58%;
Each of these stocks were significantly up year-over-year, and Q4 earnings were positive for Trulieve.
December’s 3 weakest names are all down more than 8%;
All of these stocks were down year-over-year, and Q4 was brutal for each.
The index has been recalculated as of the close of 12/31/31 and is based on data as of 12/23/23. For Q1, the index will have 27 names, down from 28 names, with three removals and two additions. AFCG, LIEN and SHFS are excluded from the index. Akanda (AKAN) and cbdMD (YCBD) are rejoining the index.
We will summarize the performance of the index again in a month. In April, we historically combined the two articles, and we update here the other indexes that New Cannabis Ventures continues to maintain: the American Cannabis Operator Index, the Ancillary Cannabis Index, and the Canadian Cannabis LP Index.
American Hemp Operator Index
ACOI rallied in December, rising 43.7% to 13.18. It rose 123.6% to 12.99 in the third quarter and ended the year up 57.7% year to date from 8.36. The large AdvisorShares Pure US Cannabis ETF ( MSOS ) was a big laggard, up 23.9%.
December’s strongest stock was Trulieve, which gained 61.2%. The weakest, Curaleaf (OTC: CURLF ) (TSX: CURA ), rose 10.4%.
In January, the index will have eleven members, with the additions of Ascend Wellness (OTC: AAWH ), Grown Rogue (GRUSF ), and Vireo Health (OTC: VREOF ).
Auxiliary cannabis index
Ancillary commodities rose 2.4% in December as the index reached 11.09. The index, which rose 14.5% to 12.72 in the third quarter, fell 12.8% in the fourth quarter. It decreased by 19.5% from 13.77 in 2025.
The strongest performing stock in December was NewLake Capital (OTC: NLCP ), which rose 24.1%. The weakest, Chicago Atlantic Real Estate Finance (NASDAQ: REFI ), fell 3.9%.
In January, the index will have the same eight members and two that are returning: iPower (NASDAQ: IPW ) and Chicago Atlantic BDC (NASDAQ: LIEN ).
Canadian Hemp LP Index
Canadian LPs rose 5.4% in December as the index fell to 59.01. The index, which increased by 78.4% in the third quarter, reaching 73.56. Declined 19.8% in Q4, but rose 17.8% in 2025 from 50.11.
The strongest Canadian LP in December was MTL Cannabis (CSE: MTL ), which jumped 62.5% after receiving a buy order. The weakest performer was Aurora Cannabis, down 10.3%.
In January, the index will have the same thirteen members.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Statistics Canada released October retail sales for the country, with Cannabis sales decline from September levels, down 4.7% to C$451.7 million. This sequential decline was further reduced on a daily basis due to the higher number of days compared to the previous month. September, originally reported at C$475.0 million, was revised slightly lower to C$473.9 million. October sales fell 0.9% year-over-year, down from 8.3% in May, 7.5% in June and 6.2% in September. This was also below the 20.3% growth rate in August 2023 and equal to the previous lowest annual growth rate since the start of legalization, which was -0.9% in September 2024, and it was significantly down from the 9.1% growth in December. August’s record level was only 1.8% higher than last year’s index. Total sales are expected to grow 4.5% to C$5.39 billion in 2024 and 4.3% year-to-date in 2025.
An increase in the number of shops, as well as a fall in the prices of flowers that attract consumers from the illegal market, have boosted sales. In Ontario, the most populous province, sales rose 0.1% from September and 3% from a year ago. Alberta grew 5.5% from September and 4% from a year ago. British Columbia was down 55.0% from September, as it was down 54% from a year ago, while Quebec was up 8.8% from September and 31% from a year ago.
November sales data will be released on January 23.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Statistics Canada released September retail sales for the country, with Cannabis sales are on the rise from August levels, down 1.4% to C$475.0 million. This sequential decline increased on a daily basis due to fewer days compared to the previous month. August, originally reported at C$498.7 million, was revised slightly higher to C$503.1 million. Sales rose 6.6% in September from a year earlier, up from 8.3% in May and 7.5% in June. This was also below the 20.3% growth rate in August 2023 and above the previous lowest annual growth since the start of legalization in September 2024 of -0.9%, and it was significantly down from the 9.1% growth in December. In August, the record growth was only 1.8% higher than the index of the previous year. Total sales grew by 4.5% to C$5.39 billion in 2024 and 4.9% year-to-date in 2025.
An increase in the number of shops, as well as a fall in the prices of flowers that attract consumers from the illegal market, have boosted sales. In Ontario, the most populous province, sales fell 5.0% from August and less than 1% from a year ago. Alberta was down 5.5% from August and 4% from a year ago. British Columbia was down 6.0% from August as it grew 1% a year ago, while Quebec was down 5.2% from August and up 48% from a year ago.
October sales data will be released on December 19.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
